Association Between Immune Dysfunction and COVID-19 Breakthrough Infection After SARS-CoV-2 Vaccination in the US

doi:10.1001/jamainternmed.2021.7024

Association Between Immune Dysfunction and COVID-19 Breakthrough Infection After SARS-CoV-2 Vaccination in the US

科研成果: 期刊稿件 › 文章 › 同行评审

源语言	英语
页（从-至）	153-162
页数	10
期刊	JAMA Internal Medicine
卷	182
期	2
DOI	https://doi.org/10.1001/jamainternmed.2021.7024
出版状态	已出版 - 2月 2022
已对外发布	是

!!!ASJC Scopus Subject Areas

内科学

联合国可持续发展目标

此成果有助于实现下列可持续发展目标：

访问文件

10.1001/jamainternmed.2021.7024

其它文件与链接

引用此

@article{4d3934d405454efabbbcca9e83621251,

title = "Association Between Immune Dysfunction and COVID-19 Breakthrough Infection After SARS-CoV-2 Vaccination in the US",

note = "Publisher Copyright: {\textcopyright} 2021 American Medical Association.",

year = "2022",

month = feb,

doi = "10.1001/jamainternmed.2021.7024",

language = "English",

volume = "182",

pages = "153--162",

journal = "JAMA Internal Medicine",

issn = "2168-6106",

publisher = "American Medical Association",

number = "2",

}

TY - JOUR

T1 - Association Between Immune Dysfunction and COVID-19 Breakthrough Infection After SARS-CoV-2 Vaccination in the US

PY - 2022/2

Y1 - 2022/2

UR - http://www.scopus.com/inward/record.url?scp=85122097033&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85122097033&partnerID=8YFLogxK

U2 - 10.1001/jamainternmed.2021.7024

DO - 10.1001/jamainternmed.2021.7024

M3 - Article

C2 - 34962505

AN - SCOPUS:85122097033

SN - 2168-6106

VL - 182

SP - 153

EP - 162

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

IS - 2

ER -

Association Between Immune Dysfunction and COVID-19 Breakthrough Infection After SARS-CoV-2 Vaccination in the US

!!!ASJC Scopus Subject Areas

联合国可持续发展目标

访问文件

其它文件与链接

指纹

引用此